Flunisolide nasal spray in the treatment of perennial rhinitis

dc.contributor.author	Joubert, J. R.	en_ZA
dc.date.accessioned	2011-03-18T14:57:41Z
dc.date.available	2011-03-18T14:57:41Z
dc.date.issued	1983
dc.description	CITATION: Joubert, J. R. 1983. Flunisolide nasal spray in the treatment of perennial rhinitis. South African Medical Journal, 64:623-624.
dc.description	The original publication is available at http://www.samj.org.za
dc.description.abstract	Twenty patients with perennial rhinitis took part in a double-blind, randomized, cross-over comparison of flunisolide nasal spray (Syntaris; Syntex) and its vehicle. The sprays were used twice daily for 4 weeks and a total daily dose of 200 μg flunisolide was used. Flunisolide was superior to the placebo in relieving sneezing, runny nose and nose-blowing (P < 0.05). Patient and doctor treatment preferences were significantly in favour of the active spray. Side-effects were mainly confirmed to nasal irritation and occurred equally in both treatment groups.
dc.description.version	Publisher’s version
dc.identifier.issn	2078-5135 (online)
dc.identifier.issn	0256-9574 (print)
dc.identifier.uri	http://hdl.handle.net/10019.1/7578
dc.language.iso	en
dc.publisher	Health & Medical Publishing Group
dc.rights.holder	South African Medical Journal
dc.subject	Rhinitis	en_ZA
dc.title	Flunisolide nasal spray in the treatment of perennial rhinitis	en_ZA
dc.type	Article

Now showing 1 - 1 of 1